Patients in the early cCRT group exhibited a trend toward longer mOS (38.3 months) compared to those in the late cCRT group (29.5 months), although this difference did not reach statistical significance (hazard ratio [HR] 0.624; 95% confidence interval [CI] 0.350–1.110; p = 0.058) (Figure 2C ).
← all excerpts
Real-World Analysis of Treatment Patterns in Limited-Stage Small Cell Lung Cancer: Implications for Clinical Practice.
2
0.0580
0.0580
The sentences
Early cCRT showed a trend toward longer mOS (38.3 months) than late cCRT (29.5 months), though not statistically significant.